J Menopausal Med.
2017 Apr;23(1):77-77. 10.6118/jmm.2017.23.1.77.
Erratum to: Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Cheomdan Hospital, Gwangju, Korea.
- 2Department of Obstetrics and Gynecology, Chosun University Hospital, Gwangju, Korea. bimilo@hanmail.net
- 3Department of Obstetrics and Gynecology, Chosun University School of Medicine, Gwangju, Korea.
- KMID: 2378229
- DOI: http://doi.org/10.6118/jmm.2017.23.1.77
Abstract
- The author and author's affiliation should be corrected.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density
- The changes of bone mineral density and biochemical bone markers after GnRH agonist treatment in patients with endometriosis
- Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis
- The effective of ultrashort-term gonadotropin-releasing hormone agonist administration in controlled ovarian hyperstimulation for in vitro fertilization
- Three Cases of Parenchymal Pulmonary Endometriosis
